Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRESY
2626
Cresud
CRESY
$795M
| $780K | ﹤0.01% |
118,793
+52,621
| +80% | +$393K |
|
2627
WesBanco
WSBC
$3.97B
| $780K | ﹤0.01% |
31,947
-26,168
| -45% | -$680K |
|
2628
PagSeguro Digital
PAGS
$2.69B
| $779K | ﹤0.01% |
90,438
-120,399
| -57% | -$1.13M |
|
2629
ITT
ITT
$17.5B
| $778K | ﹤0.01% |
7,950
-1,500
| -16% | -$147K |
|
2630
FB Financial Corp
FBK
$3.02B
| $777K | ﹤0.01% |
27,398
-15,447
| -36% | -$479K |
|
2631
Anavex Life Sciences
AVXL
$255M
| $776K | ﹤0.01% |
118,446
-5,614
| -5% | -$44.7K |
|
2632
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
| $776K | ﹤0.01% |
19,634
+2,532
| +15% | +$102K |
|
2633
Invesco Large Cap Value ETF
PWV
$1.68B
| $775K | ﹤0.01% |
16,569
-73
| -0.4% | -$3.48K |
|
2634
Supernus Pharmaceuticals
SUPN
$2.59B
| $773K | ﹤0.01% |
28,023
-21,395
| -43% | -$651K |
|
2635
SLM Corp
SLM
$4.89B
| $771K | ﹤0.01% |
56,595
-31,292
| -36% | -$471K |
|
|
DCPH
2636
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $771K | ﹤0.01% |
60,580
-25,943
| -30% | -$358K |
|
2637
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.37B
| $770K | ﹤0.01% |
8,218
+45
| +0.6% | +$4.22K |
|
|
PPLI
2638
People Inc
PPLI
$3.09B
| $770K | ﹤0.01% |
18,634
+1,603
| +9% | +$77.8K |
|
2639
STAAR Surgical
STAA
$1.21B
| $770K | ﹤0.01% |
19,163
+2,434
| +15% | +$114K |
|
2640
Brunswick
BC
$5.13B
| $768K | ﹤0.01% |
9,723
+742
| +8% | +$61.1K |
|
2641
Modine Manufacturing
MOD
$10.7B
| $768K | ﹤0.01% |
16,787
-12,652
| -43% | -$531K |
|
2642
Noble Corp
NE
$6.77B
| $765K | ﹤0.01% |
15,097
-34,465
| -70% | -$1.76M |
|
2643
Vishay Intertechnology
VSH
$5.25B
| $762K | ﹤0.01% |
30,830
-60,454
| -66% | -$1.63M |
|
2644
Westlake Chemical Partners
WLKP
$763M
| $762K | ﹤0.01% |
35,038
| – | – |
|
2645
Genmab
GMAB
$17.7B
| $760K | ﹤0.01% |
21,545
+12,863
| +148% | +$490K |
|
2646
First Trust Energy AlphaDEX Fund
FXN
$388M
| $758K | ﹤0.01% |
43,540
-2,109
| -5% | -$36.1K |
|
2647
Brookfield Asset Management
BAM
$77.3B
| $757K | ﹤0.01% |
22,626
+788
| +4% | +$26.6K |
|
2648
Genesis Energy
GEL
$1.87B
| $757K | ﹤0.01% |
73,381
-24,426
| -25% | -$241K |
|
2649
Cabaletta Bio
CABA
$437M
| $756K | ﹤0.01% |
49,695
+42,078
| +552% | +$575K |
|
2650
Aldeyra Therapeutics
ALDX
$92.9M
| $755K | ﹤0.01% |
113,036
+29,031
| +35% | +$215K |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.